Complementary, Alternative Medicine Use High in Cancer Patients
FRIDAY, April 12, 2019 -- One-third of patients with cancer and cancer survivors report using complementary and alternative medicine (CAM), and many do not disclose use to physicians, accord
FDA Approves Balversa
FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer
April 12, 2019 -- The U.S. Food and Drug Administration today granted accelerated approval to Balversa (erdafitinib), a treatment for adult patien
FDA Approves Evenity
FDA Approves Evenity (romosozumab-aqqg) for the Treatment of Osteoporosis in Postmenopausal Women at High Risk of Fracture
April 9, 2019 -- The U.S. Food and Drug Administration today approved Evenity (romosozumab-aqqg) to treat o
Best Practices Developed for Diagnosing, Managing MINOCA
TUESDAY, April 2, 2019 -- In an American Heart Association scientific statement published online March 27 in Circulation, best practices are presented for diagnostic evaluation and management of my
FDA Approves Mavenclad
FDA Approves Mavenclad (cladribine) Tablets for Multiple Sclerosis
March 29, 2019 -- The U.S. Food and Drug Administration today approved Mavenclad (cladribine) tablets to treat relapsing forms of multiple sclerosis (MS) in adul
FDA Says Patients Can Take Tainted Blood Pressure Meds Until Shortages End
FRIDAY, April 5, 2019 -- As Americans face shortages of widely used blood pressure drugs due to contamination with potentially cancer-causing impurities, the U.S. Food and Drug Ad